2020
$140M
from 15 investors over 15 rounds
Shoreline Biosciences, Inc. raised $140M on November 2, 2021
Investors: NS Investment, Kingdon Capital Management, Wedbush Securities, Irving Investors, Stork Capital S.à.r.l., -, -, Eventide Asset Management and Piper Sandler
Shoreline Biosciences, Inc. raised $43M on February 7, 2021
Investors: -, Stork Capital S.à.r.l., Commodore Capital, LP, Gilead Capital LP, Logos Global Management, LP and Cormorant Capital